STIs

Testing

Prevention

Treatments

Desire

Women

Telehealth

Can You Use Your Insurance for STI Testing?

Contents

The short answer

Yes — most U.S. health insurance plans are legally required to cover some STI testing at 100%, with no copay and no deductible. But which tests are covered depends on your gender, your sexual orientation or behavior, your age, how often you’re tested, and — critically — how your doctor codes the visit. A lot of people walk into their doctor’s office thinking “STI testing is free” and walk out with a bill for several hundred dollars. Understanding the rules is the difference between those two outcomes.

This article explains where the coverage requirement comes from, exactly which infections are covered for whom, how often, and the single most important thing you can say to your doctor to avoid a surprise bill.

Where the “free STI testing” rule actually comes from

Two things need to exist in the same sentence to understand U.S. insurance coverage for preventive care: a piece of legislation, and a government-affiliated expert committee.

The Affordable Care Act (2010)

The Affordable Care Act, signed in March 2010, contains a provision called Section 2713¹ (codified at 42 U.S.C. § 300gg-13). Section 2713 requires most private health insurers and Medicaid expansion programs to cover certain evidence-based preventive services without any patient cost-sharing — no copay, no coinsurance, and no deductible. This provision currently benefits roughly 100 to 150 million Americans each year.

But the ACA itself doesn’t list which preventive services are covered. Instead, it defers that decision to a small expert committee most people have never heard of.

The United States Preventive Services Task Force (USPSTF)

The U.S. Preventive Services Task Force is an independent, volunteer panel of 16 national experts in primary care and prevention, created in 1984. Members are appointed by the Secretary of Health and Human Services, serve four-year terms, and are drawn from fields like internal medicine, family medicine, pediatrics, OB-GYN, behavioral health, and nursing. Per the Agency for Healthcare Research and Quality (AHRQ), which administratively supports the Task Force, “USPSTF members meet three times a year for 2 days in the Washington, DC area.”

The USPSTF reviews evidence and assigns each preventive service a letter grade:

Grade A – Recommended. High certainty of substantial net benefit.
Grade B – Recommended. High certainty of moderate benefit, or moderate certainty of moderate-to-substantial benefit.
Grade C – Recommended only for select patients.
Grade D – Recommended against.
I Statement – Insufficient evidence to recommend for or against.

Here’s the rule you need to memorize: If the USPSTF gives a service an A or B grade, the ACA requires non-grandfathered insurance plans to cover it at 100% with no cost-sharing. If it gets a C, D, or I — insurance doesn’t have to cover it for free, and usually won’t.

The 2025 Supreme Court ruling

In June 2025, the Supreme Court decided Kennedy v. Braidwood Management² 6–3, upholding the constitutionality of the USPSTF structure and preserving the ACA’s preventive services mandate. As of the date of this article, all current USPSTF A and B grades remain in effect and legally covered at zero cost. The ruling did, however, affirm that the HHS Secretary can remove Task Force members at will and block recommendations before they take effect, which means future changes are possible.

What STIs does your insurance actually have to cover?

Here’s where it gets uncomfortable: the USPSTF makes different recommendations for different groups of people. A heterosexual man and a 22-year-old woman walking into the same doctor’s office with the same request will have wildly different insurance coverage — because the Task Force has concluded there’s enough evidence to recommend screening for one and not the other.

Below is the current state of USPSTF recommendations relevant to STI testing.

Currently Grade A or B (must be covered at 100%)

Service	Grade	Population	Source
Chlamydia screening	B	All sexually active women 24 and younger; women 25+ at increased risk	USPSTF, 2021
Gonorrhea screening	B	All sexually active women 24 and younger; women 25+ at increased risk	USPSTF, 2021
HIV screening	A	All adolescents and adults ages 15 to 65; younger and older at-risk; all pregnant persons	USPSTF, 2019
Syphilis screening	A	Non-pregnant adolescents/adults at increased risk; all pregnant persons	USPSTF
Hepatitis B screening	B (nonpregnant); A (pregnancy)	Adolescents and adults at increased risk; all pregnant persons at first prenatal visit	USPSTF
Hepatitis C screening	B	All adults 18 to 79	USPSTF
HIV preexposure prophylaxis (PrEP)	A	Adolescents and adults at increased risk of HIV acquisition	USPSTF, 2023
Behavioral counseling to prevent STIs	B	All sexually active adolescents and adults at increased risk	USPSTF, 2020

What this means in practice

If you are a woman aged 24 or younger and sexually active, your insurance must cover chlamydia and gonorrhea screening at no cost. You also get HIV, hepatitis C, behavioral counseling, and — if at-risk — syphilis and hepatitis B, all free.

If you are a heterosexual man, the situation is very different. In its 2021 update, the USPSTF explicitly stated that “the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men” — an I statement, not an A or B grade. As a heterosexual man, your insurance is not federally required to cover chlamydia or gonorrhea screening. HIV and hepatitis C are still covered because those recommendations apply to all adults. But the two most commonly requested bacterial STI tests? Not mandated. Some insurers still cover them; many charge you the full negotiated lab price against your deductible.

If you are a man who has sex with men (MSM), particularly one taking PrEP, you get the most comprehensive coverage. Because PrEP itself is a Grade A recommendation, the ACA’s coverage requirement extends to the associated monitoring labs — which, per both USPSTF guidance and CDC PrEP guidelines, include HIV, syphilis, chlamydia, and gonorrhea screening at regular intervals. For people on PrEP, STI testing is essentially built into the prescription.

Not covered (and why)

Herpes (HSV-1/HSV-2) serologic screening — The USPSTF gave this a Grade D, recommending against routine serologic screening in asymptomatic adolescents and adults, including pregnant persons (reaffirmed in 2023). The concern is a high false-positive rate and the psychosocial harm of inaccurate diagnosis. Your insurance will almost never cover a routine herpes blood test.
Mycoplasma genitalium — The USPSTF has no screening recommendation for this emerging STI. Per the CDC’s 2021 STI Treatment Guidelines, Mycoplasma genitalium management focuses on symptomatic cases and persistent urethritis — not asymptomatic screening. Insurance plans generally will not cover it as preventive.
Trichomonas (Trichomonas vaginalis) — Also no USPSTF screening recommendation for the general population. The CDC recommends considering trichomonas screening for women with HIV or at high risk, but there is no routine-screening recommendation that triggers ACA coverage.
HPV testing in men — No USPSTF screening recommendation. Covered for cervical cancer screening in women; not for men.
Expanded multi-panel STI tests — These typically contain a mix of covered and uncovered components. Insurance may cover the chlamydia and gonorrhea parts for an eligible patient but bill you for the herpes, Mycoplasma, and trichomonas components.

This is why patients who ask their doctor for “the full STI panel” often end up with an unexpected bill for a few hundred dollars. Some of what was ordered was covered; some of it wasn’t; and nobody told them in advance.

How often will insurance cover STI testing?

The USPSTF itself generally doesn’t specify a testing interval. In the 2021 chlamydia/gonorrhea recommendation, the Task Force noted that “a reasonable approach to screening frequency would be for clinicians to screen any patients whose sexual history reveals new or continued risk factors since their last negative test result.”

In the real world, this translates to a few practical patterns:

General population: Most insurance plans will cover covered STI screening once per 12-month period. Ask for a second annual screening without documented new risk and you may get denied.
Men who have sex with men (MSM): The CDC’s STI Treatment Guidelines recommend that sexually active MSM be screened for gonorrhea, chlamydia, and syphilis at least annually, and every 3 to 6 months for those with multiple partners, on PrEP, or otherwise at higher risk.
PrEP users: STI testing is part of the standard PrEP monitoring schedule, historically at every PrEP visit (every 3 months), though recent research is examining whether 6-month intervals are non-inferior. Insurance typically covers testing at the prescribed PrEP monitoring cadence because it’s tied to an A-graded preventive service.

The screening-versus-diagnostic trap

This is the single most important section of this article. Even when a test is theoretically “covered for free,” how your doctor codes the visit decides whether you actually pay nothing or get stuck with a bill.

There are two billing categories, and they use the exact same lab tests:

Screening means you have no symptoms, no known exposure, and you’re being tested routinely as preventive care. Screening is what the ACA covers at 100% for eligible patients.

Diagnostic means there’s a specific clinical reason to test — you have symptoms, you had a known exposure, a partner told you they tested positive, or your last test was abnormal. Diagnostic testing is subject to your deductible, your copay, and your coinsurance. Diagnostic testing costs money.

Same test. Same lab. Same doctor. Different code. Different price.

The diagnosis code is what determines the billing category. For STI screening, the codes you want on your claim are ICD-10 Z11.3 (“encounter for screening for infections with a predominantly sexual mode of transmission”) or Z11.4 (“encounter for screening for HIV”). If the visit is coded with a symptom or suspected-condition code instead — for example, N34.2 (urethritis) or R30.0 (dysuria) — the claim will process as diagnostic, not preventive.

What this means for you

Before your appointment, tell your doctor clearly:

“I’m asymptomatic. I have no known exposures. I want routine STI screening, and I’d like it billed as preventive under Z11.3 [and Z11.4 if HIV is included].”

If your doctor asks whether you have any symptoms, answer honestly — but understand that mentioning “well, maybe a little burning” can flip the visit from screening to diagnostic and move the bill from your insurance to your wallet. If you genuinely have symptoms, you likely need clinical evaluation, not routine screening; those are different encounters, and it’s legitimate for one to be coded diagnostically. What you want to avoid is an ambiguous visit getting coded the more expensive way by default.

Why this is genuinely impossible to figure out in advance

Even people who work in healthcare find insurance STI coverage confusing. Whether a given test at a given visit will actually be covered depends on at least the following variables:

The type of insurance you have — employer-sponsored PPO, HMO, or HDHP; ACA marketplace; Medicaid; Medicare; TRICARE; uninsured cash pay. Rules differ in every bucket.
Whether your employer plan is “self-funded” — about two-thirds of employer-covered workers are in self-funded plans, which under the federal ERISA law are exempt from most state insurance mandates.
Whether your plan is “grandfathered” — plans that haven’t materially changed since March 2010 are exempt from the ACA preventive mandate entirely.
Your gender, age, and behavioral risk profile — which determines which USPSTF recommendations apply to you.
Which infections you actually want tested for — some are covered, some aren’t, and a comprehensive panel will usually contain both.
Whether your doctor’s office is in-network — the ACA’s zero-cost mandate only applies in-network.
Whether the lab your sample is sent to is in-network — separate from the doctor. A common bill trap: in-network doctor, out-of-network lab.
How your doctor codes the visit — screening vs. diagnostic.
Your state’s insurance laws — some states add protections; self-funded employer plans often escape them.

You can call your insurance company and ask in advance, and you should. But the representative on the phone will frequently give you a general answer (“yes, STI screening is covered”) that turns out not to apply to your specific test, your specific code, and your specific lab — and you don’t find out until the Explanation of Benefits arrives a few weeks later with a number on it.

This is the experience a lot of patients at Shameless Care describe: they went to their regular doctor expecting free testing, asked for a thorough panel, and got a bill for several hundred dollars for the components their insurance didn’t consider medically necessary or preventive.

Where Shameless Care fits in

Full disclosure: Shameless Care is owned by the author of this article — a heterosexual man whose own insurance would not cover chlamydia, gonorrhea, or syphilis screening under the current USPSTF recommendations. That personal frustration is part of what built this company.

Shameless Care does not take insurance. We charge a flat cash price. Our 14-panel comprehensive STI test is $260 after coupon — a price that is the same for everyone regardless of gender, orientation, age, coding, or plan type. We test for the infections you actually want tested for, including the ones insurance-driven care often leaves out (Mycoplasma genitalium, trichomonas, herpes if requested). There is no EOB sent to a parent or spouse, no deductible, no billing games.

For some people — particularly young women under 24, pregnant patients, and MSM on PrEP — using insurance through a primary care or sexual health provider can genuinely be cheaper than paying cash, and we encourage it. For many others, especially heterosexual men and anyone who wants a more complete panel than what federal law mandates, cash-pay testing like ShamelessCare is often cheaper, faster, and easier than fighting insurance for partial coverage.

The point of this article is not to push one over the other. The point is that you should get to choose with real information, instead of wandering into a system that was built to confuse you.

Key takeaways

The ACA requires non-grandfathered insurance plans to cover USPSTF Grade A and B preventive services at 100%, with no copay, coinsurance, or deductible.
The USPSTF is a 16-member volunteer panel appointed by the HHS Secretary that meets three times a year in Washington, D.C., and its letter grades drive what insurance must cover.
The Supreme Court upheld the preventive services mandate in Kennedy v. Braidwood (June 2025). Current A and B grades remain in force.
Covered STI screening is heavily gendered and risk-stratified: women under 25 and pregnant persons get the most coverage; heterosexual men have the least (an I statement, not a B grade, for chlamydia/gonorrhea); MSM on PrEP get comprehensive coverage because it’s bundled with a Grade A recommendation.
Herpes serologic screening (Grade D), Mycoplasma genitalium, trichomonas in the general population, and HPV in men are not covered as preventive.
Most insurance plans will cover STI screening once per 12 months unless there’s documented new risk.
The single biggest determinant of whether you pay is screening-vs-diagnostic coding. Tell your doctor, clearly, that you’re asymptomatic and want routine screening billed under ICD-10 Z11.3 (and Z11.4 for HIV).
Because coverage depends on plan type, state, gender, orientation, tests requested, coding, and network status, it’s genuinely difficult to verify cost in advance. Cash-pay options like Shameless Care exist to sidestep that complexity entirely.

Sources

Get valuable knowledge like this, straight to your inbox once a week.

No spam, no sales pitches. Just knowledge. Unsubscribe any time, and we’ll never sell your information.